These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 25928075)
1. Cervical Cancer Screening in Average-Risk Women: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians. Sawaya GF; Kulasingam S; Denberg TD; Qaseem A; Ann Intern Med; 2015 Jun; 162(12):851-9. PubMed ID: 25928075 [TBL] [Abstract][Full Text] [Related]
2. Summaries for Patients. Cervical Cancer Screening in Average-Risk Women. Ann Intern Med; 2015 Jun; 162(12):I-28. PubMed ID: 25928137 [No Abstract] [Full Text] [Related]
3. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Moyer VA; Ann Intern Med; 2012 Jun; 156(12):880-91, W312. PubMed ID: 22711081 [TBL] [Abstract][Full Text] [Related]
4. The Korean guideline for cervical cancer screening. Min KJ; Lee YJ; Suh M; Yoo CW; Lim MC; Choi J; Ki M; Kim YM; Kim JW; Kim JH; Park EW; Lee HY; Lim SC; Cho CH; Hong SR; Dang JY; Kim SY; Kim Y; Lee WC; Lee JK J Gynecol Oncol; 2015 Jul; 26(3):232-9. PubMed ID: 26197860 [TBL] [Abstract][Full Text] [Related]
5. Gynecologists and human papillomavirus DNA testing: exploring knowledge, attitudes, and practice in Italy. Caglioti C; Pileggi C; Nobile CG; Pavia M Eur J Cancer Prev; 2017 May; 26(3):249-256. PubMed ID: 27879494 [TBL] [Abstract][Full Text] [Related]
6. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488 [TBL] [Abstract][Full Text] [Related]
7. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969 [TBL] [Abstract][Full Text] [Related]
8. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma. Li Z; Austin RM; Guo M; Zhao C Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617 [TBL] [Abstract][Full Text] [Related]
9. Cervical cancer screening among women aged 18-30 years - United States, 2000-2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2013 Jan; 61(51-52):1038-42. PubMed ID: 23282861 [TBL] [Abstract][Full Text] [Related]
10. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China. Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972 [TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening among women who attend sexually transmitted diseases (STD) clinics: background paper for 2010 STD Treatment Guidelines. Datta SD; Saraiya M Clin Infect Dis; 2011 Dec; 53 Suppl 3():S153-9. PubMed ID: 22080268 [TBL] [Abstract][Full Text] [Related]
12. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening. Bidus MA; Maxwell GL; Kulasingam S; Rose GS; Elkas JC; Chernofsky M; Myers ER Obstet Gynecol; 2006 May; 107(5):997-1005. PubMed ID: 16648402 [TBL] [Abstract][Full Text] [Related]
14. Squamous cell carcinoma of the cervix: a cytology-histology-human papillomavirus correlation in clinical practice. Miller RA; Waters LL; Mody DR; Tams KC Arch Pathol Lab Med; 2015 Jun; 139(6):776-81. PubMed ID: 26030246 [TBL] [Abstract][Full Text] [Related]
15. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Wright TC; Schiffman M; Solomon D; Cox JT; Garcia F; Goldie S; Hatch K; Noller KL; Roach N; Runowicz C; Saslow D Obstet Gynecol; 2004 Feb; 103(2):304-9. PubMed ID: 14754700 [TBL] [Abstract][Full Text] [Related]
16. Utilization patterns of cervical cancer screening in Italy. Barbadoro P; Ricciardi A; Di Tondo E; Vallorani S; Mazzarini G; Prospero E Eur J Cancer Prev; 2015 Mar; 24(2):135-40. PubMed ID: 24977627 [TBL] [Abstract][Full Text] [Related]
17. Attitudes toward the American Cancer Society's 2020 cervical cancer screening guidelines: A qualitative study of a national sample of US clinicians. Michel AD; Fontenot HB; Fuzzell L; Brownstein NC; Lake P; Vadaparampil ST; Perkins RB Cancer; 2024 Jul; 130(13):2325-2338. PubMed ID: 38436396 [TBL] [Abstract][Full Text] [Related]
18. Cervical Cancer Screening: Evolution of National Guidelines and Current Recommendations. Khan MJ Clin Obstet Gynecol; 2023 Sep; 66(3):470-477. PubMed ID: 37436937 [TBL] [Abstract][Full Text] [Related]
19. Should U.S. women be screened for cervical cancer with pap tests, HPV tests, or both? Perkins RB; Stier EA Ann Intern Med; 2014 Aug; 161(4):295-7. PubMed ID: 24912666 [No Abstract] [Full Text] [Related]
20. Assessing Cervical Cancer Screening Coverage Using a Population-Based Behavioral Risk Factor Survey--Thailand, 2010. Joseph R; Manosoontorn S; Petcharoen N; Sangrajrang S; Senkomago V; Saraiya M J Womens Health (Larchmt); 2015 Dec; 24(12):966-8. PubMed ID: 26653868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]